Company / Operating Cash Flow
vTv Therapeutics Inc. Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$19.1M
FY2025
5-year range
-$23.0M / -$16.0M
FY2021-FY2025
Trend
-19.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has fluctuated over the past 10 years, ranging from -$48M in FY2018 to -$16M in FY2024.
Based on SEC 10-K filings.
-$19M in FY2025.
Remained stable around -$19M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow decreased 19.1% year-over-year.
- Peak operating cash flow was recorded in FY2024.
- Lowest operating cash flow in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$19.1M | -19.1% |
| FY2024 | -$16.0M | +17.0% |
| FY2023 | -$19.3M | -7.3% |
| FY2022 | -$18.0M | +21.8% |
| FY2021 | -$23.0M | +14.3% |
| FY2020 | -$26.9M | +39.7% |
| FY2019 | -$44.6M | +7.6% |
| FY2018 | -$48.2M | -30.5% |
| FY2017 | -$36.9M | -20.0% |
| FY2016 | -$30.8M | +26.2% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026